aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Use this ATYR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ATYR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ATYR SEC filings page. Lician reads the product cache first so this HTML stays unique to aTyr Pharma, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full ATYR income, balance, and cash tables.